Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users (DRIVEMINDII)
DRIVE-Mind II (Drug Use & Infections in ViEtnam: Mental Health Intervention for INjecting Drug Users) Impact of Sustained Psychiatric Intervention for People Who Inject Drugs on Their Viral Exposure and Mental Health in Haiphong, Vietnam
Sponsor: ANRS, Emerging Infectious Diseases
This observational or N/A phase trial investigates Drug Use and Psychiatric Disorder and is currently completed. ANRS, Emerging Infectious Diseases leads this study, which shows 6 recorded versions since 2022 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.
Status Flow
Change History
6 versions recorded-
Apr 16, 2026 — Present [daily]
Completed
Status: Unknown → Completed · Phase: NA → None
-
Feb 2026 — Apr 2026 [monthly]
Unknown NA
Status: Active Not Recruiting → Unknown
-
Sep 2024 — Feb 2026 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Feb 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
▶ Show 1 earlier version
-
Jul 2023 — Feb 2024 [monthly]
Recruiting NA
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
The main objective of this study is to show that People Who Inject Drugs (PWID) suffering initially from a major depressive disorder, a psychotic disorder and/or had a suicide risk and who received a community-based psychiatric intervention improve sustainably their mental health and are comparable after intervention to a population of PWID free of these disorders in terms of: * HIV/HCV exposure * Severity of substance use * Quality of life This is prospective one-year cohort study comparing 200 PWID diagnosed with a psychiatric disorder with 400 controls (200 PWID living with HIV and 200 PWID non-infected with HIV, both free of a diagnosis of depression, psychosis, suicidal risk at cohort initiation). Psychiatric intervention includes free psychiatric consultations and medications (issued on CBO sites), support from CBO members for appointments, information, treatment adherence, contact with families and tracing of those lost to follow-up. Target population and controls will also be proposed linkage to care (HIV, methadone) and harm reduction services.
Contact Information
- ANRS, Emerging Infectious Diseases
- Center for supporting Community Developement Initiatives Hai Phong
- Centre Pierre Nicole Croix-Rouge française
- Haiphong University of Medicine and Pharmacy
- Université Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .